Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Idiopathic Parkinson's Disease Parkinson's Disease Basal Ganglia Disease Brain Diseases Central Nervous System Diseases Movement Disorders Nervous System Diseases Neurodegenerative Diseases Parkinsonian Disorders Gene Therapy PD Aromatic L- Amino Acid Decarboxylase AADC AAV2-AADC AAV2 Viral Vector Gene Transfer MRI PET VY-AADC01 Parkinson Disease Basal Ganglia Diseases Disease Dopa Decarboxylase VY-AADC01 Single Dose
Lead Scientist at UCSF
- Paul Larson
Dr. Paul Larson is Professor and Vice Chair of Neurological Surgery at the University of California San Francisco, Chief of Neurosurgery at the San Francisco VA Medical Center and Surgical Director of the Parkinson’s Disease Research, Education and Clinical Center. He specializes in functional neurosurgery, specifically deep brain stimulation for movement disorders and MR-guided procedures.